STC: Starting the Conversation

Sponsor
University of Ulm (Other)
Overall Status
Terminated
CT.gov ID
NCT04107714
Collaborator
(none)
5
1
2
19
0.3

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate the group-based intervention "Starting the Conversation" as a webinar in Germany. Feasibility and efficacy of the program will be tested in a pilot randomized-controlled trial (RCT).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: STC
Phase 2

Detailed Description

Parents of children with mental illness often experience public and self-stigma, and keeping a child's mental illness secret is a common strategy to avoid stigma. Both secrecy and disclosure have pros and cons for parents and their children. Therefore, the decision whether, when, and to whom to disclose a child's mental illness is complex. Interventions can provide guidance for systematic consideration and a well informed decision.

The manualized peer-led group intervention "Honest, Open, Proud" (HOP) supports people with mental illness in their decision whether to disclose mental illness. Research showed positive effects of the intervention on stigma stress, disclosure-related distress and quality of life. Based on HOP, "Starting the Conversation" (STC) was developed to systematically guide parents through their decision whether and how to disclose a child's mental illness.

At the moment, there is no data regarding feasibility and efficacy of STC, but two pilot RCTs of STC are currently underway, one in Western Australia and one in Wisconsin, USA. The aim of the current study is to evaluate feasibility and efficacy of STC as a webinar in a pilot RCT in German.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Starting the Conversation (STC) - Web-based Group Intervention to Support Disclosure Decisions for Parents of Children With Mental Illness
Actual Study Start Date :
Oct 1, 2019
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
May 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention (STC)

Study participants randomized to the experimental group receive the intervention (STC). STC is a peer-led and web-based group intervention containing four two-hour sessions within four weeks plus an additional booster session one month later. Fidelity to manual is rated in each session by study staff.

Behavioral: STC
The peer-led and web-based group program contains four lessons plus one booster session: Lesson 1: Consider the pros and cons of disclosing: Participants reflect on their experience of self-stigma and weight their pros and cons of (non-)disclosing their child's mental illness. Lesson 2: Different ways to disclose: Participants learn about different ways to disclose and their respective pros and cons. Afterwards participants discuss possible responses they might experience and develop strategies to cope with. Lesson 3: Communication about disclosure between parents and their child: Participants discuss pros and cons of (non-)disclosure for their children and how to negotiate whether to disclose or not. Lesson 4: Telling your story: Participants learn how to tell their own story. In a booster session, participants discuss their experiences with disclosure or non-disclosure.

No Intervention: No intervention

Participants randomized to the control group do not receive the group program but get the accompanying workbook at the end of the study.

Outcome Measures

Primary Outcome Measures

  1. Self-stigma of parents [8 weeks]

    Parent's Self-Stigma Scale (PSSS) (Eaton et al., 2018), 11 items rated from 1 to 5, sum score (range 5-55) with higher scores indicating more self-stigma.

Secondary Outcome Measures

  1. Self-stigma of parents [baseline, 4 weeks, 16 weeks]

    Parent's Self-Stigma Scale (PSSS) (Eaton et al., 2018), 11 items rated from 1 to 5, sum score (range 5-55) with higher scores indicating more self-stigma.

  2. Self-stigma of parents [baseline, 4 weeks, 8 weeks, 16 weeks]

    Self-Stigma in Relatives of People with Mental Illness Scale (SSRMI) (Morris et al., 2018), 10 items rated from 1 to 5, mean score across all items (range 1-5) with higher scores indicating more self-stigma.

  3. Stigma stress related to child's mental illness [baseline, 4 weeks, 8 weeks, 16 weeks]

    Stigma Stress Scale (Rüsch et al., 2009a,b) adapted for parents of children with mental illness, 8 items rated from 1 to 7 with 4 items measuring the primary appraisal of stigma as harmful and 4 items measuring the secondary appraisal of perceived resources to cope with stigma-related harm, for each of the two subscales there is a mean score (range 1-7), and a total stigma stress score will be calculated by subtracting perceived resources from perceived harm with higher difference scores (range -6 to +6) indicating more stigma stress.

  4. Parenting distress [baseline, 4 weeks, 8 weeks, 16 weeks]

    Parenting Stress Index, parent domain (PSI) (Tröster, 2011), 28 items rated from 1 to 5, sum scores of subscales (range 4-20) and across all items (range 28-140) with higher scores indicating more parenting distress.

  5. Quality of life of parents [baseline, 4 weeks, 8 weeks, 16 weeks]

    World Health Organization Quality of Life Assessment-short form (WHOQOL-BREF), domains general quality of life, psychological and social relationships (Angermeyer, Kilian & Matschinger, 2000), 11 items rated from 1 to 5, mean scores of each domain (range 1-5) with higher scores indicating better quality of life.

  6. Parent-rated child quality of life [baseline, 4 weeks, 8 weeks, 16 weeks]

    KIDSCREEN-10, parent version (The KIDSCREEN Group Europe, 2006), 10 items rated from 1 to 5, sum score across all items (range 5-50) with higher scores indicating better child quality of life.

  7. Self-esteem [baseline, 4 weeks, 8 weeks, 16 weeks]

    Rosenberg Self-Esteem Scale (RSE) (Collani & Herzberg, 2003), 10 items rated from 0 to 3, sum score across all items (range 0-30) with higher scores indicating higher self-esteem.

  8. Social support [baseline, 4 weeks, 8 weeks, 16 weeks]

    Perceived Social Support Questionnaire (FsozU K-6) (Kliem et al., 2015), 6 items rated from 1 to 5, mean score across all items (range 1-5) with higher scores indicating more perceived social support.

  9. Social inclusion [baseline, 4 weeks, 8 weeks, 16 weeks]

    Social Inclusion Scale (SIS) (Hacking et al., 2008; Secker et al., 2009) adapted for parents of children with mental illness, 20 items rated from 1 to 4, mean scores (range 1-4) of subscales and across all items with higher scores indicating higher social inclusion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parent with at least one child or adolescent that (i) is aged between 6 to 17 years (ii) has a current mental disorder according to ICD-10 diagnosed by a psychiatrist or psychologist

  • Age ≥ 18 years

  • Positive screening for disclosure distress (1 item: "In general, how distressed or worried are you in terms of secrecy or disclosure of the mental illness of your child?", self-report, persons with a score ≥ 4 on a scale from 1-7 were included)

  • Online informed consent

  • Sufficient German language skills

Exclusion Criteria:
  • Intellectual disability of child (IQ<70, self-report)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Child and Adolescent Psychiatry, University of Ulm Ulm Germany 89073

Sponsors and Collaborators

  • University of Ulm

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nicolas Rüsch, Professor, University of Ulm
ClinicalTrials.gov Identifier:
NCT04107714
Other Study ID Numbers:
  • 375/18
First Posted:
Sep 27, 2019
Last Update Posted:
May 7, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nicolas Rüsch, Professor, University of Ulm
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 7, 2021